A third biotechnology company from the startup creator Paragon Therapeutics is heading to the public markets. Paragon’s Oruka Therapeutics, which is developing biologic drugs for chronic skin diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback